Sugammadex 100 mg/mL solution for injection Irlanda - inglês - HPRA (Health Products Regulatory Authority)

sugammadex 100 mg/ml solution for injection

msn labs europe limited - sugammadex sodium - solution for injection - sugammadex

SUGAMMADEX- sugammadex injection Estados Unidos - inglês - NLM (National Library of Medicine)

sugammadex- sugammadex injection

patheon manufacturing services llc - sugammadex (unii: 361lpm2t56) (sugammadex sodium - unii:erj6x2mxv7) - sugammadex 500 mg in 5 ml

Sugammadex Sandoz 100 mg/ml inj. sol. i.v. vial Bélgica - inglês - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sugammadex sandoz 100 mg/ml inj. sol. i.v. vial

sandoz sa-nv - sugammadex sodium 108,8 mg/ml - eq. sugammadex 100 mg/ml - solution for injection - 100 mg/ml - sugammadex sodium 108.8 mg/ml - sugammadex

Sugammadex Sandoz 100 mg/ml inj. sol. i.v. vial Bélgica - inglês - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sugammadex sandoz 100 mg/ml inj. sol. i.v. vial

sandoz sa-nv - sugammadex sodium 108,8 mg/ml - eq. sugammadex 100 mg/ml - solution for injection - 100 mg/ml - sugammadex sodium 108.8 mg/ml - sugammadex

Sugammadex BNM Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

sugammadex bnm

boucher & muir (new zealand) limited t/a bnm group - sugammadex sodium 108.8 mg/ml equivalent to sugammadex 100mg/ml - solution for injection - 200 mg/2ml - active: sugammadex sodium 108.8 mg/ml equivalent to sugammadex 100mg/ml excipient: hydrochloric acid sodium hydroxide water for injection - sugammadex is indicated for the reversal of neuromuscular blockade induced by rocuronium or vecuronium.

Sugammadex Reddy 100 mg/ml inj. sol. i.v. vial Bélgica - inglês - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sugammadex reddy 100 mg/ml inj. sol. i.v. vial

reddy holding gmbh - sugammadex sodium 108,8 mg/ml - eq. sugammadex 100 mg/ml - solution for injection - 100 mg/ml - sugammadex sodium 108.8 mg/ml - sugammadex

Sugammadex Reddy 100 mg/ml inj. sol. i.v. vial Bélgica - inglês - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sugammadex reddy 100 mg/ml inj. sol. i.v. vial

reddy holding gmbh - sugammadex sodium 108,8 mg/ml - eq. sugammadex 100 mg/ml - solution for injection - 100 mg/ml - sugammadex sodium 108.8 mg/ml - sugammadex

Sugammadex Teva 100 mg/ml inj. sol. i.v. vial Bélgica - inglês - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sugammadex teva 100 mg/ml inj. sol. i.v. vial

teva b.v. - sugammadex sodium 108,8 mg/ml - eq. sugammadex 100 mg/ml - solution for injection - 100 mg/ml - sugammadex sodium 108.8 mg/ml - sugammadex

Sugammadex Teva 100 mg/ml inj. sol. i.v. vial Bélgica - inglês - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sugammadex teva 100 mg/ml inj. sol. i.v. vial

teva b.v. - sugammadex sodium 108,8 mg/ml - eq. sugammadex 100 mg/ml - solution for injection - 100 mg/ml - sugammadex sodium 108.8 mg/ml - sugammadex

SUGAMMADEX- sugammadex injection SUGAMMADEX- sugammadex injection, solution Estados Unidos - inglês - NLM (National Library of Medicine)

sugammadex- sugammadex injection sugammadex- sugammadex injection, solution

camber pharmaceuticals, inc. - sugammadex sodium (unii: erj6x2mxv7) (sugammadex - unii:361lpm2t56) - sugammadex injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults undergoing surgery.  pediatric use information is approved for merck sharp & dohme corp., a subsidiary of merck & co. inc.’s bridion ® (sugammadex injection). however, due to merck sharp & dohme corp., a subsidiary of merck & co. inc.’s marketing exclusivity rights, this drug product is not labeled with that information. sugammadex is contraindicated in patients with known hypersensitivity to sugammadex or any of its components. hypersensitivity reactions that occurred varied from isolated skin reactions to serious systemic reactions (i.e., anaphylaxis, anaphylactic shock) and have occurred in patients with no prior exposure to sugammadex [see warnings and precautions (5.1), adverse reactions (6)].  risk summary  there are no clinical trial data on sugammadex use in pregnant women to inform any drug-associated risks. the available data from